Diligent360 is an end-to-end Vendor management platform, built for the clinical trials industry. Diligent360 unifies the entire Vendor lifecycle from discovery and qualification through ongoing monitoring, so you can reduce delays, make risk-based decisions, and stay ahead of evolving compliance demands.
Study Intelligence is Cybroscape's AI software for clinical study data, part of the Cybroscape platform alongside GxP Copilot and TraceDraft. It brings sample, biomarker, clinical operations and vendor data from every CRO, lab and biorepository into one governed view of each study. Each sample is matched to its subject, visit, consent status, location and assay results, and mismatches are raised as they appear rather than at database lock. Study agents answer questions in plain English and cite the records behind every answer. They can draft routine work, such as a shipment reconciliation or a destruction list for withdrawn consent, for a person to review and approve; they never change source data on their own. Vendor-neutral, it works with the CROs, labs and biorepositories a sponsor already uses. Study data flows into TraceDraft for clinical documents, and the platform is validated with GxP Copilot.